This Cooperative Agreement award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $1,201,568 to the Boston VA Research Institute, Inc. (BVARI) to implement genomic medicine across diverse Veteran communities through the VA's Genomics-Enabled Learning Health System. Key products and services include:
-
Identifying and sharing with a network of healthcare systems an implementation approach and strategies with high potential for scaling genomic medicine interventions, including in under-resourced settings.
-
Proposing and conducting three implementation trials across the network focused on pharmacogenomic testing, germline testing to inform cancer treatment, and EHR-based identification of unrecognized monogenic diseases.
-
Collaborating with the network to execute implementation projects for genomic medicine interventions targeting diverse patient populations and clinical conditions within the VA system and its communities, with a focus on recruiting underserved populations.
The award period runs from September 2024 to July 2029. It also includes a $223,000 sub-award to the Northern California Institute For Research And Education, Inc. to provide subject matter expertise and project management support.
Generated 3/4/25, 6:12 AM